Old News First!: SkinBioTherapeutics announces a deal to develop new cosmetic skincare ingredients based on pioneering skin microbiome research.
By Elric Langton | 9 October 2022
In late 2019, almost three years ago, SkinBioTherapeutics Plc (AIM: SBTX) announced its first commercial agreement with FTSE100 stalwart Croda International Plc (LSE: CRDA). Leavβ¦